Health state utilities associated with adult attention-deficit/hyperactivity disorder

References

• BiedermanJMonuteauxMCMickEYoung adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up studyPsychol Med200636216717916420713
   PubMed Web of Science ®Google Scholar
• FaraoneSVBiedermanJWhat is the prevalence of adult ADHD? Results of a population screen of 966 adultsJ Atten Disord20059238439116371661
   PubMedGoogle Scholar
• KesslerRCAdlerLABarkleyRPatterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replicationBiol Psychiatry200557111442145115950019
   PubMed Web of Science ®Google Scholar
• MannuzzaSKleinRGMoultonJL3rdPersistence of Attention- Deficit/Hyperactivity Disorder into adulthood: what have we learned from the prospective follow-up studies?J Atten Disord2003729310015018358
   PubMedGoogle Scholar
• BrazierJRRatcliffeJSalomonJATsuchiyaAMeasuring and Valuing Health benefits for Economic EvaluationNew YorkOxford University Press2007
   Google Scholar
• CoghillDSpendeQBartonJMeasuring Quality of Life in Children with Attention-Deficit-Hyperactivity Disorder in the UKPoster presented at 16th World Congress of the International Association for Child and Adolescent Psychiatry and Allied Professions (IACAPAP)22–26, August 2004Berlin, Germany2004
   Google Scholar
• LloydAHodgkinsPSasaneREstimation of utilities in attention- deficit hyperactivity disorder for economic evaluationsPatient20114424725721995830
   PubMedGoogle Scholar
• MatzaLSSecnikKRentzAMAssessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy reportQual Life Res200514373574716022066
   PubMed Web of Science ®Google Scholar
• SecnikKMatzaLSCottrellSEdgellETildenDMannixSHealth state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdomMed Decis Making2005251567015673582
   PubMed Web of Science ®Google Scholar
• Van BruntKMatzaLSClassiPMJohnstonJAPreferences related to attention-deficit/hyperactivity disorder and its treatmentPatient Prefer Adherence20115334321311700
   PubMed Web of Science ®Google Scholar
• ZimovetzEASetyawanJBeardSMHodgkinsPSystemic review of health-state utilities in Attention Deficit Hyperactivity Disorder (ADHD)Presented at: ISPOR 15th Annual European CongressNovember 3–7, 2012Berlin
   Google Scholar
• LaingAAristidesMAttention deficit hyperactivity disorder (ADHD) in adults: SF-6D utilities from SF-36 scores in a randomised trialPresented at: 8th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes ResearchNovember 6–8, 2005Florence
   Google Scholar
• BrazierJRobertsJDeverillMThe estimation of a preference-based measure of health from the SF-36J Health Econ200221227129211939242
   PubMed Web of Science ®Google Scholar
• AaproMAbrahamssonPABodyJJGuidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panelAnn Oncol200819342043217906299
   PubMed Web of Science ®Google Scholar
• BodyJJDielIJBellROral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancerPain2004111330631215363874
   PubMed Web of Science ®Google Scholar
• ColemanREMetastatic bone disease: Clinical features, pathophysiology and treatment strategiesCancer Treat Rev200127316517611417967
   PubMed Web of Science ®Google Scholar
• ColemanREGuiseTALiptonAAdvancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge ConferenceClin Cancer Res200814206387639518927277
   PubMed Web of Science ®Google Scholar
• RosenLSGordonDTchekmedyianNSLong-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trialCancer2004100122613262115197804
   PubMed Web of Science ®Google Scholar
• SmithHSPainful osseous metastasesPain Physician2011144E373E40321785487
   PubMed Web of Science ®Google Scholar
• WeinfurtKPLiYCastelLDThe significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancerAnn Oncol200516457958415734776
   PubMed Web of Science ®Google Scholar
• AdlerLCohenJDiagnosis and evaluation of adults with attention-deficit/hyperactivity disorderPsychiatr Clin North Am200427218720115063992
   PubMed Web of Science ®Google Scholar
• BiedermanJFaraoneSVSpencerTJMickEMonuteauxMCAleardiMFunctional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the communityJ Clin Psychiatry200667452454016669717
   PubMed Web of Science ®Google Scholar
• KooijSJBejerotSBlackwellAEuropean consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDBMC Psychiatry2010106720815868
   PubMed Web of Science ®Google Scholar
• MannuzzaSCastellanosFXRoizenERHutchisonJALashuaECKleinRGImpact of the impairment criterion in the diagnosis of adult ADHD: 33-year follow-up study of boys with ADHDJ Atten Disord201115212212920378923
   PubMed Web of Science ®Google Scholar
• RiccioCAWolfeMDavisBRomineCGeorgeCLeeDAttention Deficit Hyperactivity Disorder: manifestation in adulthoodArch Clin Neuropsychol200520224926915708734
   PubMed Web of Science ®Google Scholar
• WilensTEBiedermanJFaraoneSVMartelonMWesterbergDSpencerTJPresenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHDJ Clin Psychiatry200970111557156220031097
   PubMed Web of Science ®Google Scholar
• ConnersCKErhardtDSparrowEConners’ Adult ADHD Rating Scales, Technical ManualNew York, NYMulti-Health Systems Inc1999
   Google Scholar
• AdlerLASpencerTFaraoneSVValidity of pilot adult ADHD self-report scale (pilot ASRS) to rate adult ADHD symptomsPresented at: American Academy of Child and Adolescent PsychiatryOctober 14–19, 2003Miami, FL
   Google Scholar
• AdlerLAZimmermanBStarrHLEfficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation studyJ Clin Psychopharmacol200929323924719440077
   PubMed Web of Science ®Google Scholar
• BiedermanJMickESurmanCA randomized, placebo- controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorderBiol Psychiatry200659982983516373066
   PubMed Web of Science ®Google Scholar
• BiedermanJMickESurmanCA randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorderJ Clin Psychopharmacol201030554955320814332
   PubMed Web of Science ®Google Scholar
• CasasMRöslerMSandra KooijJJEfficacy and safety of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a 13-week, randomized, double-blind, placebo-controlled, fixed-dose studyWorld J Biol Psychiatry201314426828122106853
   PubMed Web of Science ®Google Scholar
• MedoriRRamos-QuirogaJACasasMA randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorderBiol Psychiatry2008631098198918206857
   PubMed Web of Science ®Google Scholar
• RetzWRoslerMOseCMultiscale assessment of treatment efficacy in adults with ADHD: a randomized placebo-controlled, multi-centre study with extended-release methylphenidateWorld J Biol Psychiatry2012131485921155632
   PubMed Web of Science ®Google Scholar
• WeislerRHPandinaGJDalyEJCooperKGassmann-Mayer C; InvestigatorsATTSRandomized clinical study of a histamine H3 receptor antagonist for the treatment of adults with attention-deficit/hyperactivity disorderCNS Drugs201226542143422519922
   PubMed Web of Science ®Google Scholar
• WinhusenTMSomozaECBrighamGSDoes treatment of Attention Deficit Hyperactivity Disorder (ADHD) enhance response to smoking cessation intervention in ADHD smokers? A randomized trialJ Clin Psychiatry201071121680168820492837
   PubMed Web of Science ®Google Scholar
• BrodMJohnstonJAbleSSwindleRValidation of the adult attention-deficit/hyperactivity disorder quality-of-life Scale (AAQoL): a disease-specific quality-of-life measureQual Life Res200615111712916411036
   PubMed Web of Science ®Google Scholar
• BrazierJValuing health States for use in cost-effectiveness analysisPharmacoeconomics200826976977918767897
   PubMed Web of Science ®Google Scholar
• NICE (National Institute for Health and Clinical Excellence)Process and methods guides: Guide to the methods of technology appraisal 2013LondonNational Institute for Health and Care Excellence2013 Available from: http://www.nice.org.uk/media/D45/1E/GuideToMethodsTechnologyAppraisal2013.pdfAccessed September 10, 2013
   Google Scholar
• PBACGuidelines for preparing submissions to the Pharmaceutical Benefits Advisory CommitteeCanberra, AustraliaPBAC62013 Version 4.4: http://www.pbac.pbs.gov.au/content/information/printable-files/pbacg-book.pdfAccessed May 22, 2014
   Google Scholar
• DolanPModeling valuations for EuroQol health statesMed Care19973511109511089366889
   PubMed Web of Science ®Google Scholar
• NICE (National Institute for Health and Clinical Excellence)Guide to the methods of technology appraisalLondonNational Institute for Health and Care Excellence2008 Available from: http://www.nice.org.uk/media/b52/a7/tamethodsguideupdatedjune2008.pdfAccessed September 10, 2013
   Google Scholar
• RowenDBrazierJHealth Utility MeasurementGliedSSmithPCThe Oxford Handbook of Health EconomicsNew YorkOxford University Press2011788813
   Google Scholar
• DolanPGudexCKindPWilliamsAThe time trade-off method: results from a general population studyHealth Econ1996521411548733106
   PubMed Web of Science ®Google Scholar
• YangYBrazierJTsuchiyaAEffect of adding a sleep dimension to the EQ-5D descriptive system: a “bolt-on” experimentMed Decis Making2014341425323525702
   PubMed Web of Science ®Google Scholar
• GerardKDobsonMHallJFraming and labelling effects in health descriptions: quality adjusted life years for treatment of breast cancerJ Clin Epidemiol199346177848433117
   PubMed Web of Science ®Google Scholar
• SackettDLTorranceGWThe utility of different health states as perceived by the general publicJ Chronic Dis19783111697704730825
   PubMedGoogle Scholar
• RowenDBrazierJTsuchiyaAYoungTIbbotsonRIt’s all in the name, or is it? The impact of labeling on health state valuesMed Decis Making2012321314021685376
   PubMed Web of Science ®Google Scholar
• KrabbePFTrompNRuersTJvan RielPLAre patients’ judgments of health status really different from the general population?Health Qual Life Outcomes201193121569351
   PubMed Web of Science ®Google Scholar
• PeetersYStiggelboutAMHealth state valuations of patients and the general public analytically compared: a meta-analytical comparison of patient and population health state utilitiesValue Health201013230630919744288
   PubMed Web of Science ®Google Scholar
• UbelPALoewensteinGJepsonCWhose quality of life? A commentary exploring discrepancies between health state evaluations of patients and the general publicQual Life Res200312659960714516169
   PubMed Web of Science ®Google Scholar
• CADTH (Canadian Agency for Drugs and Technologies in Health)Guidelines for the economic evaluation of health technologies: Canada3rd edOttawa, ONCanadian Agency for Drugs and Technologies in Health2006
   Google Scholar